BD (Becton, Dickinson and Company) has announced a development and global distribution agreement with Check-Points for BD MAX assays that detect carbapenem-resistant organisms (CRO).
As part of the agreement, BD will distribute the Check-Direct CPE Screen for the BD MAX assay (CE IVD) outside of the US, with Check-Points maintaining exclusivity in the Netherlands. Check-Points and BD plan to develop and commercialise a next-generation CRO assay for launch outside the US in 2017.
As the UK’s leading provider of hospital engineering, decontamination and estates & FM training within healthcare, Eastwood Park’s accredited training is delivered to NHS Trusts and private medical organisations not only within the UK but worldwide.
Manchester, Etihad Stadium
11th September 2025
Business School, University of Nottingham
20th September 2025
Stansted Radisson Blu
23rd September 2025
Brighton Centre, UK
29th - 30th September 2025
Mathematical Institute, University of Oxford
4th October 2025
Blackpool
7th - 8th October 2025
